Erik Bengtsen, MD, described what sets psycho-oncology apart and how clinicians can open conversations on body image and sexual health.
|Slideshows|February 12, 2016
Highlights From the 2016 ASCO Cancer Survivorship Symposium
Author(s)Cancer Network Editors
This slide show includes some of the top highlights from the 2016 ASCO Cancer Survivorship Symposium, including studies on whether lymphoma survivors receive the recommended care, how personalization improved survivorship care plan adherence among breast cancer patients, and more.
Advertisement
Advertisement
Related to this article
Ursula A. Matulonis, MD, discussed how biomarkers, adverse effects, and patient preference guide choices among recent platinum-resistant ovarian cancer approvals.
Alexandra Dreyfuss, MD, MS, explains why CAR T and bispecific populations are her priority for prospective radiotherapy studies in multiple myeloma.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Ralph V. Boccia, MD, FACP, explained how community practices can build the workflow and capacity to deliver bispecific step-up dosing in an outpatient setting.
There is a gap in prospective data for radiation use in multiple myeloma, according to Alexandra Dreyfuss, MD, MS.
Erik Bengtsen, MD, explained how antidepressants may improve quality of life and how he typically works with patients who decline favorable treatment.
Nikolai Strusberg, MD, discussed how proton therapy and thyroid dose affect clinical hypothyroidism risk after supraclavicular breast radiation.
Advertisement
Advertisement
Trending on CancerNetwork
1
VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors
2
Operationalizing the First Dose and Building the Oncology and Eye Care Partnership
3
Reading a Changed Eye Examination and Impact on Therapy
4
Personalized Cancer Vaccine Combo Is Feasible in Platinum-Sensitive Ovarian Cancer
5